Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
1.930
+0.230 (13.53%)
At close: Sep 16, 2026, 4:00 PM EDT
1.965
+0.035 (1.80%)
After-hours: Sep 16, 2026, 5:14 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $24.67 million as of September 16, 2026. Its market cap has decreased by -40.03% in one year.
Market Cap
24.67M
Enterprise Value
17.35M
1-Year Change
-40.03%
Ranking
Category
Stock Price
$1.93
ChartMarket Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $30.33M to $24.67M, a decrease of -18.65%. That is a compound annual growth rate of -3.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 24.67M | -27.19% |
| Dec 31, 2025 | 33.89M | -1.50% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 27.34M |
| CEL-SCI | 26.03M |
| Evaxion | 25.44M |
| Radiopharm Theranostics | 24.75M |
| Atossa Therapeutics | 24.15M |
| Actuate Therapeutics | 23.95M |
| Tvardi Therapeutics | 23.08M |
| TScan Therapeutics | 22.43M |